Poly Medicure Limited has informed the Exchange about Investor s Presentation on Acquisition of Pendracare Group (a unique interventional cardiology consumable asset in Europe.
POLYMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Poly Medicure Limited has informed the exchange about an investor presentation covering its acquisition of Pendracare Group. Pendracare is described as a unique interventional cardiology consumable asset based in Europe. The filing shares the presentation with investors to explain the strategic rationale and details of the deal. This acquisition strengthens Poly Medicure's footprint in the cardiology consumables segment and expands its presence in the European market.
This acquisition signals international expansion into a specialised cardiology segment, which could boost long-term revenue and product portfolio. Short-term stock movement may depend on deal valuation and integration outlook shared in the presentation.